PM Modi unveiled three innovations at ESTIC 2025: two quantum computing technologies and India's first indigenous cancer therapy, enhancing cyber and healthcare advancements. | Latest News India ...

On November 6, 2025, Shanghai, China, CorrectSequence Therapeutics Co., Ltd. (Correctseq), a clinical-stage biotechnology ...

The management of advanced thyroid cancer requires careful consideration of histology, molecular profiling, and treatment ...

Benitec Biopharma Inc. (Nasdaq: BNTC) ('Benitec” or the 'Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary DNA- ...

Q3 2025 Management View CEO Shankar Musunuri highlighted the company's rapid progress on its modifier gene therapy platform, noting "in just over 3 years, we brought our lead candidate, OCU400, from ...

For autologous cell and gene therapies (CGTs), the collection of patients‘ cells is the first step in the manufacture of the medicinal product.

The gene p53 acts as a tumor suppressor and is often called the guardian of the genome. This gene is central to maintaining genomic stability, which prevents mutations from accumulating and leading to ...

India has achieved a major milestone in medical science with NexCAR19, the world’s first humanised CAR-T (Chimeric Antigen Receptor T-cell) therapy, which has made gene-based cancer treatments both ...

The Chimeric Antigen Receptor T-cell (CAR-T) therapy has emerged as a breakthrough in cancer treatment, with global clinical ...

Pfizer and Novo Nordisk continue to fight for ownership of obesity startup Metsera; CDER Director George Tidmarsh leaves his ...

Investing.com -- Mizuho upgraded Sarepta Therapeutics Inc to Outperform from Neutral and raised its price target to $26 from $19, citing stronger-than-expected sales of its gene therapy Elevidys and ...

Q3 2025 Earnings Call Transcript November 4, 2025 Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS ...